Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.69
(
-0.96%
)
Bitcoin
74,367.61
(
0.58%
)
News Focus
News Focus

Replies to post #9044 on Momenta Pharmaceuticals, Inc. (MNTA)

Replies to #9044 on Momenta Pharmaceuticals, Inc. (MNTA)
icon url

DewDiligence

11/01/12 8:17 AM

#9868 RE: DewDiligence #9044

3Q12 US Copaxone sales were $775M; US sales of Copaxone for the first 9 months of 2012 were $2.09B, ahead of the pace to meet my estimate of $2.6B for the full year (#msg-75932272).